Ebronucimab - Research Grade Biosimilar, CAS [[2304800-90-4]], Unconjugated, Monoclonal
Artikelnummer:
PRS-21-906
Artikelname: |
Ebronucimab - Research Grade Biosimilar, CAS [[2304800-90-4]], Unconjugated, Monoclonal |
Artikelnummer: |
PRS-21-906 |
Hersteller Artikelnummer: |
21-906 |
Alternativnummer: |
PRS-21-906-0.1 |
Hersteller: |
ProSci |
Kategorie: |
Antikörper |
Immunogen: |
Homo sapiens / PCSK9 |
Konjugation: |
Unconjugated |
Alternative Synonym: |
EBRONUCIMAB [INN],IMMUNOGLOBULIN G1, ANTI-(HUMAN NEURAL APOPTOSIS-REGULATED CONVERTASE 1) (HUMAN MONOCLONAL AK102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AK102 .LAMBDA.-CHAIN, DIMER,IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(HOMO SAPIENS PCSK9 (PROPROTEIN |
Klonalität: |
Monoclonal |
Konzentration: |
batch dependent |
NCBI: |
255738 |
UniProt: |
Q8NBP7 |
Puffer: |
PBS buffer pH 7.5 |
Quelle: |
CHO cells |
Reinheit: |
>95% |
CAS Nummer: |
[2304800-90-4] |
Application Verdünnung: |
For research use only . |